1649 related articles for article (PubMed ID: 23680671)
1. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
[TBL] [Abstract][Full Text] [Related]
2. Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partner.
Park KG; Lee KM; Seo HY; Suh JH; Kim HS; Wang L; Won KC; Lee HW; Park JY; Lee KU; Kim JG; Kim BW; Choi HS; Lee IK
Diabetes; 2007 Feb; 56(2):431-7. PubMed ID: 17259388
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase is associated with apoptosis in β cells and contributes to insulin-dependent diabetes mellitus pathogenesis.
Zhang B; Yang L; Yu L; Lin B; Hou Y; Wu J; Huang Q; Han Y; Guo L; Ouyang Q; Zhang B; Lu L; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):207-16. PubMed ID: 22236578
[TBL] [Abstract][Full Text] [Related]
4. Increased vulnerability to β-cell destruction and diabetes in mice lacking NAD(P)H:quinone oxidoreductase 1.
Yeo SH; Noh JR; Kim YH; Gang GT; Kim SW; Kim KS; Hwang JH; Shong M; Lee CH
Toxicol Lett; 2013 May; 219(1):35-41. PubMed ID: 23458895
[TBL] [Abstract][Full Text] [Related]
5. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
6. Recovery from diabetes in neonatal mice after a low-dose streptozotocin treatment.
Kataoka M; Kawamuro Y; Shiraki N; Miki R; Sakano D; Yoshida T; Yasukawa T; Kume K; Kume S
Biochem Biophys Res Commun; 2013 Jan; 430(3):1103-8. PubMed ID: 23257160
[TBL] [Abstract][Full Text] [Related]
7. The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic beta-cell apoptosis and its dysfunction in streptozotocin-treated mice.
Kim JY; Song EH; Lee S; Lim JH; Choi JS; Koh IU; Song J; Kim WH
Cell Signal; 2010 Nov; 22(11):1669-80. PubMed ID: 20600850
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Arafat HA; Lada E; Katakam AK; Amin N
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):555-62. PubMed ID: 17177137
[TBL] [Abstract][Full Text] [Related]
9. Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models.
Liadis N; Salmena L; Kwan E; Tajmir P; Schroer SA; Radziszewska A; Li X; Sheu L; Eweida M; Xu S; Gaisano HY; Hakem R; Woo M
Diabetes; 2007 Sep; 56(9):2302-11. PubMed ID: 17563067
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death.
Jain D; Weber G; Eberhard D; Mehana AE; Eglinger J; Welters A; Bartosinska B; Jeruschke K; Weiss J; Päth G; Ariga H; Seufert J; Lammert E
PLoS One; 2015; 10(9):e0138535. PubMed ID: 26422139
[TBL] [Abstract][Full Text] [Related]
11. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
[TBL] [Abstract][Full Text] [Related]
12. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
13. Trigonelline inhibits caspase 3 to protect β cells apoptosis in streptozotocin-induced type 1 diabetic mice.
Liu L; Du X; Zhang Z; Zhou J
Eur J Pharmacol; 2018 Oct; 836():115-121. PubMed ID: 30130525
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of intraislet ghrelin enhances β-cell proliferation after streptozotocin-induced β-cell injury in mice.
Bando M; Iwakura H; Ariyasu H; Koyama H; Hosoda K; Adachi S; Nakao K; Kangawa K; Akamizu T
Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E140-8. PubMed ID: 23651849
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor: a new player associated with apoptosis and proliferation of pancreatic beta-cell in type 1 diabetes mellitus.
Li RJ; Qiu SD; Wang HX; Tian H; Wang LR; Huo YW
Apoptosis; 2008 Aug; 13(8):959-71. PubMed ID: 18543106
[TBL] [Abstract][Full Text] [Related]
16. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
17. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
18. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome.
Kai AK; Lam AK; Chen Y; Tai AC; Zhang X; Lai AK; Yeung PK; Tam S; Wang J; Lam KS; Vanhoutte PM; Bos JL; Chung SS; Xu A; Chung SK
FASEB J; 2013 Oct; 27(10):4122-35. PubMed ID: 23825225
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
[TBL] [Abstract][Full Text] [Related]
20. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
